Protocol Draft V2.pdf (180.2 kB)

Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review Protocol

online resource

posted on 2022-02-22, 01:24 authored by Yash ShahYash Shah, Amy ShaverAmy Shaver, William Kevin Kelly, Grace Lu-Yao

Scoping review protocol to determine the differential toxicities and outcomes of abiraterone acetate and enzalutamide in prostate cancer patients.

History

Usage metrics

Categories

Keywords

abirtaterone enzalutamide prostate cancer androgen deprivation therapy scoping review scoping review protocol Nephrology and Urology Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

Exports